Amid MFN Talks, Lilly Chief Warns US Adoption of International Drug Prices Could Bring ‘Worst of Two Worlds’

Eli Lilly CEO cautioned against the US adopting international reference pricing for drugs as part of 'Most Favored Nation' (MFN) talks2.

The CEO argued that importing foreign price controls into the US system could result in the 'worst of two worlds'2.

This warning comes amid ongoing discussions in the US to lower drug prices by referencing prices from other countries12.

The concern from Lilly's chief is that such a move could undermine incentives for pharmaceutical innovation and potentially restrict patient access to new medicines2.

Sources:

1. https://medwatch.com/News/Pharma_Biotech/article18418037.ece

2. https://www.fiercepharma.com/pharma/amid-mfn-talks-lilly-chief-warns-adoption-international-drug-prices-could-bring-worst-two